The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Open accessAbstract
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).Methods We analysed the COVID-19 Global Rheumatology Alliance physician registry (from 24 March 2020 to 12 April 2021). We investigated b/tsDMARD use for RA at the clinical onset of COVID-19 (baseline): abatacept (ABA), rituximab (RTX), Janus kinase inhibitors (JAKi), interleukin 6 inhibitors (IL-6i) or tumour necrosis factor inhibitors (TNFi, reference group). The ordinal COVID-19 severity outcome was (1) no hospitalisation, (2) hospitalisation without oxygen, (3) hospitalisation with oxygen/ventilation or (4) death. We used ordinal logistic regression to estimate the OR (odds of being one level higher on the ordinal outcome) for each drug class compared with TNFi, adjusting for potential baseline confounders.Results Of 2869 people with RA (mean age 56.7 years, 80.8% female) on b/tsDMARD at the onset of COVID-19, there were 237 on ABA, 364 on RTX, 317 on IL-6i, 563 on JAKi and 1388 on TNFi. Overall, 613 (21%) were hospitalised and 157 (5.5%) died. RTX (OR 4.15, 95% CI 3.16 to 5.44) and JAKi (OR 2.06, 95% CI 1.60 to 2.65) were each associated with worse COVID-19 severity compared with TNFi. There were no associations between ABA or IL6i and COVID-19 severity.Conclusions People with RA treated with RTX or JAKi had worse COVID-19 severity than those on TNFi. The strong association of RTX and JAKi use with poor COVID-19 outcomes highlights prioritisation of risk mitigation strategies for these people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous reports have also suggested a differential association of baseline use of rheumatic disease medications on outcomes (30, 31).”
From SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression
Vittinghoff, E., & McCulloch, C. E. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk052 · Cited by 4,359
Generalized Ordered Logit/Partial Proportional Odds Models for Ordinal Dependent Variables
Williams, R. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600104 · Cited by 2,118
Interleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Assessing proportionality in the proportional odds model for ordinal logistic regression.
Brant, R. (1990) · Biometrics · doi:10.2307/2532457 · Cited by 1,864
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., Marconi, V. C., Ruiz-Palacios, G. M., Hsieh, L., Kline, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031994 · Cited by 1,835
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Stone, J. H., Frigault, M. J., Serling-Boyd, N. J., Fernandes, A. D., Harvey, L., Foulkes, A. S., Horick, N. K., Healy, B. C., Shah, R., Bensaci, A. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2028836 · Cited by 1,362
Self-citationTocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Salama, C., Han, J., Yau, L., Reiss, W. G., Kramer, B., Neidhart, J. D., Criner, G. J., Kaplan-Lewis, E., Baden, R., Pandit, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030340 · Cited by 1,291
Gianfrancesco, M., Hyrich, K. L., Al-Adely, S., Carmona, L., Danila, M. I., Gossec, L., Izadi, Z., Jacobsohn, L., Katz, P., Lawson-Tovey, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217871 · Cited by 1,141
Self-citation
Cited by
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Grainger, R., Kim, A. H. J., Conway, R., Yazdany, J., & Robinson, P. C. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00755-x · Cited by 188
Self-citationConway, R., Grimshaw, A. A., Konig, M. F., Putman, M., Duarte‐García, A., Tseng, L. Y., Cabrera, D. M., Chock, Y. P. E., Degirmenci, H. B., Duff, E., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42030 · Cited by 178
“Findings from previous studies have also suggested a differential effect of baseline use of rheumatic disease medications on COVID-19 outcomes (30,31).”
Self-citationLandewé, R. B. M., Kroon, F. P. B., Alunno, A., Najm, A., Bijlsma, J. W., Burmester, G.-R. R., Caporali, R., Combe, B., Conway, R., Curtis, J. R., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-222006 · Cited by 165
Self-citationSelectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
Bonelli, M., Kerschbaumer, A., Kastrati, K., Ghoreschi, K., Gadina, M., Heinz, L. X., Smolen, J. S., Aletaha, D., O’Shea, J., & Laurence, A. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-223850 · Cited by 162
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
Leone, G. M., Mangano, K., Petralia, M. C., Nicoletti, F., & Fagone, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041630 · Cited by 160
Metadata
- Authors
- Sparks, J. A., Wallace, Z. S., Seet, A. M., Gianfrancesco, M. A., Izadi, Z., Hyrich, K. L., Strangfeld, A., Gossec, L., Carmona, L., Mateus, E. F., Lawson-Tovey, S., Trupin, L., Rush, S., Katz, P., Schmajuk, G., Jacobsohn, L., Wise, L., Gilbert, E. L., Duarte-García, A., Valenzuela-Almada, M. O., Pons-Estel, G. J., Isnardi, C. A., Berbotto, G. A., Hsu, T. Y. T., D'Silva, K. M., Patel, N. J., Kearsley-Fleet, L., Schäfer, M., Ribeiro, S. L. E., Al Emadi, S., Tidblad, L., Scirè, C. A., Raffeiner, B., Thomas, T., Flipo, R.-M., Avouac, J., Seror, R., Bernardes, M., Cunha, M. M., Hasseli, R., Schulze-Koops, H., Müller-Ladner, U., Specker, C., Souza, V. A. D., Mota, L. M. H. D., Gomides, A. P. M., Dieudé, P., Nikiphorou, E., Kronzer, V. L., Singh, N., Ugarte-Gil, M. F., Wallace, B., Akpabio, A., Thomas, R., Bhana, S., Costello, W., Grainger, R., Hausmann, J. S., Liew, J. W., Sirotich, E., Sufka, P., Robinson, P. C., Machado, P. M., Yazdany, J., Dahou, B., Quintana, R., Gómez, G., Roberts, K., Baez, R. M., Coello, V. C., Salinas, M. H., Maldonado, F. N., Reyes, A. A., Alle, G., Tanten, R., Ficco, H. M., Nieto, R., Gobbi, C., Tissera, Y., Pisoni, C., Paula, A., Albiero, J. A., Schmid, M. M., Cosatti, M., Gamba, M. J., Leandro, C., Cusa, M. A., German, N., Bellomio, V., Takashima, L., Pera, M., Cogo, K., Elkin, M. S., Medina, M. A., Savio, V., Tessel, I. R., Alamino, R. P., Werner, M. L., Ornella, S., Casalla, L., Vega, M. D. L., Severina, M., García, M., Lucero, L. G., Romeo, C., Moyano, S., Barbich, T., Bertoli, A., Baños, A., Petruzzelli, S., Matellan, C., Conti, S., Lazaro, M. A., Gil, G. F., Risueño, F., Quaglia, M. I., Scafati, J., Cuchiaro, N. L., Rebak, J. E., Pineda, S. I., Calvo, M. E., Picco, E., Yanzi, J. G., Maid, P., Guaglianone, D., Morbiducci, J. S., Porta, S., Herscovich, N., Zamora, J. L., Kisluk, B., Menescardi, M. S., Gallo, R., Martire, M. V., Maldini, C., Goizueta, C., Fernandez, S. S. D., Argentina, C. A., Subils, G., Rath, E., Piette, Y., Devinck, M., Maeyaert, B., Ribeiro, F. M., Ribeiro, S. L., Pinheiro, M., Ibáñez, S., Chassin-Trubert, A.-M., Dong, L., Cajas, L., Barešić, M., Anić, B., Čulo, M.-I., Pavelić, T. A., Stranski, K. K., Karanovic, B., Vencovsky, J., Píchová, M., Filkova, M., Hamoud, H., Vassilopoulos, D., Melgar, G. M., So, H., Király, M., Vojdanian, M., Balbir-Gurman, A., Abutiban, F., Zepa, J., Bulina, I., Bukauskiene, L., Zazueta-Montiel, B. E., Castillo-Ortiz, A. A., Zamora-Tehozol, E., Vega-Morales, D., Rosete, D. C., Martín-Nares, E., Rodriguez-Reyna, T. S., Gabayet, M. R., Alpízar-Rodríguez, D., Irazoque, F., Jimenez, X., Bon, L. G.-V., Zijlstra, T., Hoekstra, M., Al-Adhoubi, N., Salim, B., Giraldo, E., Salinas, A., Ugarte-Gil, M., Nowakowski, J., Conway, R., Flood, R., McCarthy, G., Felea, I., Filipescu, I., Rednic, S., Groseanu, L., Tamas, M. M., Mlynarikova, V., Skamlova, M., Zlnay, M., Mičeková, D., Capova, L., Macejova, Z., Šteňová, E., Raffayova, H., Belakova, G., Strakova, E., Senčarová, M., Sabová, A., Spisakova, D., Oetterová, M., Lukacova, O., Bakosova, M., Hocevar, A., Torre-Rubio, N. D. L., Sancho, J. J., Coro, M. C., Garcia, J. C., Martin, M. C., Campos, J., Puerta, J. A., Yardımcı, G. K., Akar, S., Icacan, O. C., ÇELİK, S., Vasylets, V., Yeoh, S.-A., Vandevelde, C., Dunt, S., Leeder, J., Macphie, E., Salerno, R., Graver, C., Williams, K., O'Reilly, S., Devine, K., Tyler, J., Warner, E., Pilcher, J., Patel, S., Nikiphorou, E., Chadwick, L., Jones, C. M., Harrison, B., Thornton, L., O'Kane, D., Fusi, L., Low, A., Horton, S., Jatwani, S., Baig, S., Bajwa, H., Berglund, V., Dahle, A., Dorman, W., Hargrove, J., Hilton, M., Lebedoff, N., Leonard, S., Morgan, J., Pfeifer, E., Skemp, A., Wilson, J., Wolff, A., Cepeda, E., Todd, D., Hare, D., Calabrese, C., Adams, C., Khosroshahi, A., Kilian, A., White, D., Winter, M., Fields, T., Siegel, C., Daver, N., Harvey, M., Kramer, N., Lamore, C., Hogarty, S., Yeter, K., Wise, L., Siddique, F., Ban, B., Tanner, T., Ruderman, E., Davis, W., Quinet, R., Scopelitis, E., Toribio, K. T., Webb-Detiege, T., Zakem, J., Abbass, K., Kepecs, G., Miranda, L., Guma, M., Haikal, A., Mody, S., Mueller, D., Jayatilleke, A., Zell, J., Bays, A., Dao, K., Fatemeh, E., Parks, D., Karp, D., & Quiceno, G.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of California, San Francisco (US)
- Manchester Academic Health Science Centre (GB)
- German Rheumatism Research Centre (DE)
- Inserm (FR)
- Instituto de Salud Musculoesquelética (ES)
- European League Against Rheumatism (CH)
- Mayo Clinic in Florida (US)
- Mayo Clinic (US)
- Hospital Británico de Buenos Aires (AR)
- Massachusetts General Hospital (US)
- Hospital Universitário Getúlio Vargas (BR)
- Karolinska Institutet (SE)
- Società Italiana di Reumatologia (IT)
- Ospedale di Bolzano (IT)
- Université de Lyon (FR)
- Université de Lille (FR)
- Université Paris Cité (FR)
- Universidade do Porto (PT)
- Hospital Garcia de Orta (PT)
- Justus-Liebig-Universität Gießen (DE)
- Kliniken Essen-Mitte (DE)
- Universidade Federal de Juiz de Fora (BR)
- University Center of Brasília (BR)
- Hôpital Bichat-Claude-Bernard (FR)
- University of Washington (US)
- Universidad Científica del Sur (PE)
- University of Michigan (US)
- Royal Hallamshire Hospital (GB)
- The University of Queensland (AU)
- Crystal Run Healthcare (US)
- Irish Children's Arthritis Network (IE)
- University of Otago (NZ)
- Boston Children's Hospital (US)
- Boston University (US)
- Canadian Arthritis Patient Alliance (CA)
- HealthPartners (US)
- University College London Hospitals NHS Foundation Trust (GB)
- Manchester University NHS Foundation Trust (GB)
- Corresponding author
- Sparks, Jeffrey A
- ORCID
- Sparks, Jeffrey A
- Wallace, Zachary S
- Seet, Andrea M
- Gianfrancesco, Milena A
- Izadi, Zara
- Hyrich, Kimme L
- Strangfeld, Anja
- Gossec, Laure
- Carmona, Loreto
- Mateus, Elsa F
- Lawson-Tovey, Saskia
- Trupin, Laura
- Katz, Patricia
- Schmajuk, Gabriela
- Gilbert, Emily L
- Duarte-García, Ali
- Valenzuela-Almada, Maria O
- Pons-Estel, Guillermo J
- Isnardi, Carolina A
- Berbotto, Guillermo A
- Hsu, Tiffany Y -T
- D'Silva, Kristin M
- Patel, Naomi J
- Kearsley-Fleet, Lianne
- Schäfer, Martin
- Ribeiro, Sandra Lúcia Euzébio
- Tidblad, Liselotte
- Scirè, Carlo Alberto
- Raffeiner, Bernd
- Thomas, Thierry
- Avouac, Jérôme
- Bernardes, Miguel
- Hasseli, Rebecca
- Schulze-Koops, Hendrik
- Specker, Christof
- Souza, Viviane Angelina de
- Mota, Licia Maria Henrique da
- Gomides, Ana Paula Monteiro
- Dieudé, Philippe
- Kronzer, Vanessa L
- Singh, Namrata
- Ugarte-Gil, Manuel F
- Wallace, Beth
- Akpabio, Akpabio
- Thomas, Ranjeny
- Bhana, Suleman
- Grainger, Rebecca
- Hausmann, Jonathan S
- Liew, Jean W
- Sirotich, Emily
- Sufka, Paul
- Robinson, Philip C
- Machado, Pedro M
- Yazdany, Jinoos
- Nieto, Romina
- Maldini, Carla
- Vassilopoulos, Dimitrios
- Nowakowski, Jarosław
- Yeoh, Su-Ann
- White, Douglas
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 80
- Issue
- 9
- Pages
- 1137-1146
- ISSN
- 0003-4967 (ISSN-L)
- PMC
- PMC8172266
- OpenAlex
- W3164519882
- Cited by
- 238
- References
- 35
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 28 · 2023: 59 · 2022: 69 · 2021: 49
- FWCI
- 38.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Annals of the Rheumatic Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- European Alliance of Associations for Rheumatology
- American College of Rheumatology
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Keywords
- rheumatoid arthritis, COVID-19 severity, biologic DMARDs, targeted synthetic DMARDs, rituximab, JAK inhibitors, abatacept, IL-6 inhibitors, tumor necrosis factor inhibitors, hospitalization, mortality, risk mitigation strategies
- MeSH terms
- COVID-19, SARS-CoV-2, Aged, Arthritis, Rheumatoid, Female, Humans, Male, Middle Aged, Registries, Severity of Illness Index, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. https://app.cochat.ai/papers/10.1136/annrheumdis-2021-220418
- The paper
- Sparks, J. A., Wallace, Z. S., Seet, A. M., Gianfrancesco, M. A., Izadi, Z., Hyrich, K. L., Strangfeld, A., Gossec, L., Carmona, L., Mateus, E. F., Lawson-Tovey, S., Trupin, L., Rush, S., Katz, P., Schmajuk, G., Jacobsohn, L., Wise, L., Gilbert, E. L., Duarte-García, A., . . . Quiceno, G. (2021). Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2021-220418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.